Cefdinir Powder, For Suspension
Product Images NDC 65862-219

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 65862-219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cefdinir-fig1 (Cefdinir Fig1)

Label for Cefdinir oral suspension USP 125 mg/5 mL powder for suspension, including directions for reconstitution with 38 mL water, storage instructions, dosage information, and warnings. Distributed by Aurobindo Pharma USA, Inc., the label specifies a 60 mL volume when reconstituted.*

FDA Label Image

Cefdinir-fig2 (Cefdinir Fig2)

Packaging label for Cefdinir for Oral Suspension, USP 125 mg/5 mL powder for suspension, oral use. The label indicates the product should be reconstituted with 38 mL of water to yield 60 mL when reconstituted. It includes directions for reconstitution, storage instructions, and states it is Rx only. The labeler is Aurobindo Pharma USA, Inc., with distribution information and barcode visible.*

FDA Label Image

Cefdinir-fig3 (Cefdinir Fig3)

Label for Cefdinir for Oral Suspension, USP 250 mg/5 mL powder for suspension, distributed by Aurobindo Pharma USA, Inc. Instructions include reconstitution with 38 mL water to yield 60 mL suspension, dosing and storage directions, and safety warnings. Label specifies shake well before use and discard after 10 days.*

FDA Label Image

Cefdinir-fig4 (Cefdinir Fig4)

Packaging label for Cefdinir for Oral Suspension USP, 250 mg/5 mL, powder for suspension, oral use. The label shows instructions to shake well before using, reconstitution with 38 mL water to yield 60 mL suspension, and storage information. Distributed by Aurobindo Pharma USA, Inc., with labeler Aurobindo Pharma Limited. NDC 65862-219-60 is visible.*

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure of the active ingredient Cefdinir, showing its molecular framework including beta-lactam and thiazolidine rings with various functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.